Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47494)
CDC/NIH Web Information Database (32185)
CDC-Authored Genomics and Precision Health Publications Database (5888)
Precision Health Database (63724)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (675)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226596)
Epigenetic Epidemiology Publications Database (22799)
Release Note
Contact Us
CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC-Authored Genomics and Precision Health Publications Database
Last data update: Apr 29, 2024
. (Total: 5888 publications)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
Filtered By:
Select to fine-tune your search
Year
Journal
Records 1-29 (of 29 Records)
Query Trace:
Cano M[original query]
Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013.
Moro PL
,
Harrington T
,
Shimabukuro T
,
Cano M
,
Museru OI
,
Menschik D ,
Broder K
.
Vaccine 2013 31 (43) 4984-7
Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests.
Ruhaak LR , Romijn Fphtm , Begcevic Brkovic I ,
Kuklenyik Z
,
Dittrich J , Ceglarek U , Hoofnagle AN , Althaus H , Angles-Cano E , Coassin S , Delatour V , Deprez L , Dikaios I , Kostner GM , Kronenberg F ,
Lyle A
,
Prinzing U ,
Vesper HW
,
Cobbaert CM .
Clin Chem 2023 69 (3) 251-261
Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays.
Dikaios I , Althaus H , Angles-Cano E , Ceglarek U , Coassin S , Cobbaert CM , Delatour V , Dieplinger B , Grimmler M , Hoofnagle AN , Kostner GM , Kronenberg F ,
Kuklenyik Z
,
Lyle AN
,
Prinzing U , Ruhaak LR , Scharnagl H ,
Vesper HW
,
Deprez L .
Clin Chem 2023 69 (3) 262-272
Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.
Perez-Vilar S , Dores GM ,
Marquez PL
,
Ng CS
,
Cano MV
,
Rastogi A , Lee L ,
Su JR
,
Duffy J
.
Vaccine 2021 40 (2) 247-254
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
Su JR
,
McNeil MM
,
Welsh KJ ,
Marquez PL
,
Ng C
,
Yan M
,
Cano MV
.
Vaccine 2021 39 (5) 839-845
Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014-2018.
Duffy J
,
Marquez P
,
Dores GM ,
Ng C
,
Su J
,
Cano M
,
Perez-Vilar S .
Open Forum Infect Dis 2020 7 (12) ofaa516
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.
Myers TR
,
McNeil MM
,
Ng CS
,
Li R
,
Marquez PL
,
Moro PL
,
Omer SB ,
Cano MV
.
Vaccine 2020 38 (40) 6291-6298
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
Su JR
,
Haber P
,
Ng CS
,
Marquez PL
,
Dores GM , Perez-Vilar S ,
Cano MV
.
Vaccine 2019 38 (7) 1746-1752
Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.
Haber P
,
Moro PL
,
Ng C
,
Dores GM , Perez-Vilar S ,
Marquez PL
,
Cano M
.
Vaccine 2019 38 (6) 1476-1480
Safety of the 9-Valent Human Papillomavirus Vaccine.
Shimabukuro TT
,
Su JR
,
Marquez PL
,
Mba-Jonas A ,
Arana JE
,
Cano MV
.
Pediatrics 2019 144 (6)
Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
Haber P
,
Moro PL
,
Ng C
,
Dores GM ,
Lewis P
,
Cano M
.
Vaccine 2019 37 (11) 1516-1520
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.
Suragh TA
,
Lewis P
,
Arana J
,
Mba-Jonas A ,
Li R
,
Stewart B
,
Shimabukuro TT
,
Cano M
.
Br J Clin Pharmacol 2018 84 (12) 2928-2932
Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.
Moro PL
,
Perez-Vilar S ,
Lewis P
,
Bryant-Genevier M ,
Kamiya H
,
Cano M
.
Pediatrics 2018 142 (1)
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER
,
Lewis P
,
Shimabukuro TT
,
Su J
,
Moro P
,
Woo EJ , Jankosky C ,
Cano M
.
Hum Vaccin Immunother 2018 14 (8) 1-23
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
Arana JE
,
Harrington T
,
Cano M
,
Lewis P
,
Mba-Jonas A ,
Rongxia L
,
Stewart B
,
Markowitz LE
,
Shimabukuro TT
.
Vaccine 2018 36 (13) 1781-1788
Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
Haber P
,
Moro PL
,
Ng C
,
Lewis PW
,
Hibbs B
,
Schillie SF
,
Nelson NP
,
Li R
,
Stewart B
,
Cano MV
.
Vaccine 2017 36 (4) 559-564
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
Arana J
,
Mba-Jonas A , Jankosky C ,
Lewis P
,
Moro PL
,
Shimabukuro TT
,
Cano M
.
J Adolesc Health 2017 61 (5) 577-582
Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
Myers TR
,
McNeil MM
,
Ng CS
,
Li R
,
Lewis PW
,
Cano MV
.
Vaccine 2017 35 (14) 1758-1763
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
Haber P
,
Arana J
,
Pilishvili T
,
Lewis P
,
Moro PL
,
Cano M
.
Vaccine 2016 34 (50) 6330-6334
Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.
Moro PL
,
Woo EJ , Paul W ,
Lewis P
,
Petersen BW
,
Cano M
.
PLoS Negl Trop Dis 2016 10 (7) e0004846
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.
Miller ER
,
Moro PL
,
Cano M
,
Lewis P
,
Bryant-Genevier M ,
Shimabukuro T
.
Vaccine 2016 34 (25) 2841-6
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
Haber P
,
Moro PL
,
Lewis P
,
Woo EJ , Jankosky C ,
Cano M
.
Vaccine 2016 34 (22) 2507-12
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015.
Moro PL
,
Winiecki S ,
Lewis P
,
Shimabukuro TT
,
Cano M
.
Vaccine 2015 33 (48) 6684-8
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.
Haber P
,
Moro PL
,
Cano M
,
Vellozzi C
,
Lewis P
,
Woo EJ ,
Broder K
.
J Pediatric Infect Dis Soc 2015 4 (3) 205-13
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.
Haber P
,
Moro PL
,
Cano M
,
Lewis P
,
Stewart B
,
Shimabukuro TT
.
Vaccine 2015 33 (16) 1987-92
Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.
McNeil MM
,
Cano M
,
Miller E
,
Petersen BW , Engler RJ , Bryant-Genevier MG .
Vaccine 2014 32 (37) 4758-65
Molecular characterization of Cryptosporidium spp. in children from Mexico.
Valenzuela O , Gonzalez-Diaz M , Garibay-Escobar A , Burgara-Estrella A , Cano M , Durazo M , Bernal RM , Hernandez J ,
Xiao L
.
PLoS One 2014 9 (4) e96128
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.
Moro PL
,
Arana J
,
Cano M
,
Menschik D ,
Yue X
,
Lewis P
,
Haber P
,
Martin D ,
Broder K
.
Clin Infect Dis 2012 54 (11) 1608-14
Validation and clinical application of a molecular method for the identification of Histoplasma capsulatum in human specimens in Colombia, South America
Munoz C
,
Gomez BL
,
Tobon A , Arango K , Restrepo A , Correa MM , Muskus C , Cano LE , Gonzalez A .
Clin Vaccine Immunol 2009 17 (1) 62-7
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 29, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP